United Therapeutics CorporationUnited Therapeutics CorporationUnited Therapeutics Corporation

United Therapeutics Corporation

No trades
See on Supercharts

Price target

298.160.00 0.00%
The 14 analysts offering 1 year price forecasts for UTHR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 17 analysts giving stock ratings to UTHR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

UTHR EPS for the last quarter is 6.17 USD despite the estimation of 5.71 USD. In the next quarter EPS is expected to reach 6.35 USD. Track more of United Therapeutics Corporation financials and stay on top of what is up with the company.
In the next quarter United Therapeutics Corporation revenue is expected to reach ‪674.48 M‬ USD. Check out United Therapeutics Corporation revenue and earnings and make informed decisions.
According to analysts, UTHR price target is 298.16 USD with a max estimate of 400.00 USD and a min estimate of 220.00 USD. Check if this forecast comes true in a year, meanwhile watch United Therapeutics Corporation stock price chart and keep track of the current situation with UTHR news and stock market news.
We've gathered opinions of 17 analysts rating UTHR stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.